Area of research
Hematology · Oncology
Research interest
Research interests include Hematopoietic Stem Cell Transplantation, Neutropenia and Cancer Infections, Gut microbiota and health, and Acute Myeloid Leukemia Research.
Assessing Quality of Life and Symptoms in Transplantation and CAR-T Recipients: Expert Panel Recommendations from the Survivorship Special Interest Group of ASTCT
Graft-versus-host disease prophylaxis shapes T cell biology and immune reconstitution after hematopoietic cell transplant
US Geriatric Assessment Practices for Older Adults Undergoing Hematopoietic Cell Transplantation or Chimeric Antigen Receptor T Cell Therapy: An American Society for Transplantation and Cellular Therapy Physician Survey from the Aging Special Interest Group and Committee on Practice Guidelines
Assessing cognitive function in transplantation and chimeric antigen receptor t cell therapy recipients: Expert recommendations from the survivorship, aging and biobehavioral special interest groups of the American Society for Transplantation and Cellular Therapy
Assessing Social Determinants of Health in Transplantation and CAR-T Recipients: Expert Panel Recommendations from the Survivorship Special Interest Group of ASTCT
Ibrutinib for therapy of steroid-refractory chronic graft-versus-host disease: a multicenter real-world analysis
High-resolution analyses of associations between medications, microbiome, and mortality in cancer patients
Cardiometabolic Comorbidities in Cancer Survivors
MAIT and Vδ2 unconventional T cells are supported by a diverse intestinal microbiome and correlate with favorable patient outcome after allogeneic HCT
Conditioning Regimens are Associated with Distinct Patterns of Microbiota Injury in Allogeneic Hematopoietic Cell Transplantation
Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation
The gut microbiota is associated with immune cell dynamics in humans
Multi-omics analyses of radiation survivors identify radioprotective microbes and metabolites
The microbe-derived short-chain fatty acids butyrate and propionate are associated with protection from chronic GVHD
Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: a multicenter observational study
Incidence, Risk Factors, and Outcomes of Patients Who Develop Mucosal Barrier Injury–Laboratory Confirmed Bloodstream Infections in the First 100 Days After Allogeneic Hematopoietic Stem Cell Transplant
Microtransplantation in older patients with <scp>AML</scp>: A pilot study of safety, efficacy and immunologic effects
Lactose drives <i>Enterococcus</i> expansion to promote graft-versus-host disease
Multicenter Microbiota Analysis Indicates That Pre-HCT Microbiota Injury Is Prevalent across Geography and Predicts Poor Overall Survival
Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversity
The Microbiome and Hematopoietic Cell Transplantation: Past, Present, and Future
Intestinal Microbiota Injury during Allo-Hct is Generalizable across Transplantation Centers and is Associated with Increased Mortality, Broad-Spectrum Antibiotics, and Decreased Calorie Intake
HLA-Mismatched Microtransplant in Older Patients Newly Diagnosed With Acute Myeloid Leukemia
The effect of pre-transplant pain and chronic disease self-efficacy on quality of life domains in the year following hematopoietic stem cell transplantation